Robert L. Kormos
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Robert L. Kormos has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
Jeffrey J. Teuteberg
Department of Medicine, Division of Cardiovascular Medicine, Stanford University, Stanford, California
4 shared publicationsChristopher Sciortino
Division of Cardiac Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania
2 shared publicationsDaniel J. Goldstein
Department of Cardiothoracic Surgery, Montefiore Medical Center, New York, New York
2 shared publicationsFrancis D. Pagani
Department of Cardiac Surgery, University of Michigan Health System, Ann Arbor, Michigan
2 shared publicationsJames K. Kirklin
Department of Surgery, University of Alabama at Birmingham, Birmingham, Alabama
2 shared publicationsJeffrey P. Jacobs
Division of Cardiovascular Surgery, Department of Surgery, Johns Hopkins All Children's Heart Institute, Saint Petersburg, Florida; Division of Cardiovascular Surgery, Department of Surgery, Johns Hopkins All Children's Hospital, Tampa, Florida; Division of Cardiovascular Surgery, Department of Surgery, Florida Hospital for Children, Orlando, Florida
2 shared publications
Latest Publications
- 1 March 2021
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 111 (3) , 881-888
Delineating Pathways to Death by Multisystem Organ Failure in Patients With a Left Ventricular Assist Device
- 1 March 2021
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 111 (3) , 881-888
Delineating Pathways to Death by Multisystem Organ Failure in Patients With a Left Ventricular Assist Device
- Top Cited Papers
- 1 February 2019
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 38 (2) , 114-126
The Society of Thoracic Surgeons Intermacs database annual report: Evolving indications, outcomes, and scientific partnerships
- 1 February 2019
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 38 (2) , 114-126
Top Cited PapersThe Society of Thoracic Surgeons Intermacs database annual report: Evolving indications, outcomes, and scientific partnerships
- 1 February 2019
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 107 (2) , 341-353
The Society of Thoracic Surgeons Intermacs Database Annual Report: Evolving Indications, Outcomes, and Scientific Partnerships
- 1 February 2019
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 107 (2) , 341-353
The Society of Thoracic Surgeons Intermacs Database Annual Report: Evolving Indications, Outcomes, and Scientific Partnerships
- 31 October 2017
- Published by Wolters Kluwer Health in Circulation
- Vol. 136 (18) , 1714-1725
Left Ventricular Assist Device Malfunctions
Background: Reports of left ventricular assist device (LVAD) malfunction have focused on pump thrombosis. However, the device consists of the pump, driveline, and peripherals, all of which are potentially subject to failure. Methods: Prospectively collected data were reviewed for all LVAD device malfunctions (DMs) occurring in rotary LVADs implanted at a single center between April 2004 and May 2016. Durable LVADs included 108 Heartmate II (HM II) and 105 HeartWare VAD (HVAD). DM data were categorized according to device type and into categories related to the component that failed: (1) controller, (2) peripheral components, and (3) implantable blood pump or its integral electric driveline. Pump-related events were analyzed as pump-specific (suspected or confirmed thrombosis) or nonpump-specific (driveline failure). DM rates were reported as events per 1000 patient-days, and Cox proportional hazard models were used for time-to-event analyses. Cumulative rates of malfunction were examined for the main components of each type of LVAD. Results: Types of DM included controller failure (30%), battery failure (19%), or patient cable failure (14%), whereas only 13% were because of pump failure. DMs were more common in the HM II device (3.73 per 1000 patient-days versus 3.06 per 1000 patient-days for the HVAD, P P P P P <0.02). Conclusions: Device malfunction is much broader than pump failure alone and occurs for different components at different rates based on the type of LVAD.
- 31 October 2017
- Published by Wolters Kluwer Health in Circulation
- Vol. 136 (18) , 1714-1725
Left Ventricular Assist Device Malfunctions
Background: Reports of left ventricular assist device (LVAD) malfunction have focused on pump thrombosis. However, the device consists of the pump, driveline, and peripherals, all of which are potentially subject to failure. Methods: Prospectively collected data were reviewed for all LVAD device malfunctions (DMs) occurring in rotary LVADs implanted at a single center between April 2004 and May 2016. Durable LVADs included 108 Heartmate II (HM II) and 105 HeartWare VAD (HVAD). DM data were categorized according to device type and into categories related to the component that failed: (1) controller, (2) peripheral components, and (3) implantable blood pump or its integral electric driveline. Pump-related events were analyzed as pump-specific (suspected or confirmed thrombosis) or nonpump-specific (driveline failure). DM rates were reported as events per 1000 patient-days, and Cox proportional hazard models were used for time-to-event analyses. Cumulative rates of malfunction were examined for the main components of each type of LVAD. Results: Types of DM included controller failure (30%), battery failure (19%), or patient cable failure (14%), whereas only 13% were because of pump failure. DMs were more common in the HM II device (3.73 per 1000 patient-days versus 3.06 per 1000 patient-days for the HVAD, P P P P P <0.02). Conclusions: Device malfunction is much broader than pump failure alone and occurs for different components at different rates based on the type of LVAD.
- 23 September 2017
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 155 (1) , e37-e38
Extending the perspective on left ventricular assist device pump thrombosis to left ventricular assist device system thrombosis
- 23 September 2017
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 155 (1) , e37-e38
Extending the perspective on left ventricular assist device pump thrombosis to left ventricular assist device system thrombosis
- 1 March 2015
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 149 (3) , 673-674
Left ventricular assist device pump thrombosis: Understanding mechanisms as a key to causality
- 1 March 2015
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 149 (3) , 673-674
Left ventricular assist device pump thrombosis: Understanding mechanisms as a key to causality
- 1 March 2015
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 149 (3) , 933-934
Solutions for right ventricular failure: Innovation driven by need
- 1 March 2015
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 149 (3) , 933-934
Solutions for right ventricular failure: Innovation driven by need
- 1 December 2010
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 293-298
A Classification Approach for Risk Prognosis of Patients on Mechanical Ventricular Assistance
The identification of optimal candidates for ventricular assist device (VAD) therapy is of great importance for future widespread application of this life-saving technology. During recent years, numerous traditional statistical models have been developed for this task. In this study, we compared three different supervised machine learning techniques for risk prognosis of patients on VAD: Decision Tree, Support Vector Machine (SVM) and Bayesian Tree-Augmented Network, to facilitate the candidate identification. A predictive (C4.5) decision tree model was ultimately developed based on 6 features identified by SVM with assistance of recursive feature elimination. This model performed better compared to the popular risk score of Lietz et al. with respect to identification of high-risk patients and earlier survival differentiation between high- and low-risk candidates.
- 1 December 2010
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 293-298
A Classification Approach for Risk Prognosis of Patients on Mechanical Ventricular Assistance
The identification of optimal candidates for ventricular assist device (VAD) therapy is of great importance for future widespread application of this life-saving technology. During recent years, numerous traditional statistical models have been developed for this task. In this study, we compared three different supervised machine learning techniques for risk prognosis of patients on VAD: Decision Tree, Support Vector Machine (SVM) and Bayesian Tree-Augmented Network, to facilitate the candidate identification. A predictive (C4.5) decision tree model was ultimately developed based on 6 features identified by SVM with assistance of recursive feature elimination. This model performed better compared to the popular risk score of Lietz et al. with respect to identification of high-risk patients and earlier survival differentiation between high- and low-risk candidates.
- Top Cited Papers
- 1 May 2010
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 139 (5) , 1316-1324
Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: Incidence, risk factors, and effect on outcomes
- 1 May 2010
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 139 (5) , 1316-1324
Top Cited PapersRight ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: Incidence, risk factors, and effect on outcomes